在西班牙,对患有糖尿病黄斑的患者进行疾病负担研究
José M Ruiz-Moreno1, María Gámez Lechuga2, Pilar Calvo3
1Ophtalmology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
Ophthalmology and therapy
|May 21, 2024
概括
在西班牙,糖尿病黄斑 (DMO) 的年度成本为每名患者12,233欧元至18,774欧元,其中直接医疗费用是最高的支出. 这种巨大的经济负担凸显了需要有效的DMO管理策略的需要.
科学领域:
- 眼科医生 眼科 眼科
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 糖尿病黄斑 (DMO) 是糖尿病视网膜病变的一种严重并发症,导致视力丧失并影响患者的生活质量.
- DMO对医疗保健和非医疗保健资源造成了相当大的负担,影响了患者的身体和心理健康,工作和日常活动.
研究的目的:
- 估计西班牙DMO的综合社会经济负担.
- 分析与不同治疗方式和疾病持续时间相关的成本.
主要方法:
- 社会视角成本分析,评估直接医疗保健成本 (DHC),直接非医疗保健成本 (DNHC),劳动生产率损失 (LPL) 和无形成本 (IC).
- 费用是按患者,治疗年和治疗类型 (拉尼比祖马布,阿弗利伯塞普特,德克萨米他植入物) 计算的.
- 资源利用率乘以单位价格,成本参考为2021年.
主要成果:
- 平均年度DMO成本在治疗的第一年从12,233欧元到18,774欧元不等,在随后的几年下降.
- 直接医疗保健成本占总成本的最大比例,其次是劳动生产率损失.
- 还确定了一次性诊断成本为485欧元.
结论:
- 糖尿病黄斑对患者,医疗保健系统和社会产生重大社会经济影响.
- 越来越多的DMO患病率需要积极的医疗保健策略来预防视力丧失和减轻疾病的经济负担.
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


